Realbotix Earnings Call Transcripts
Fiscal Year 2026
-
Resolved prior financial control issues, exited crypto, and strengthened cash position. Scaling robotics and AI segments, with strong client demand and a major Nasdaq deal pending. Company remains debt-free and sees itself as undervalued by the market.
-
A reverse takeover will move the commercial robotics business into a Nasdaq-listed vehicle, giving current shareholders 75–90% ownership and access to new capital without dilution or share consolidation. The deal separates business lines, enhances growth prospects, and is expected to close in 3–6 months.
Fiscal Year 2025
-
Realbotix showcased its advanced, modular humanoid robots with lifelike vision, multilingual AI, and patented features, targeting hospitality, retail, and healthcare. The company plans to scale production, lower costs, and expand subscription services, emphasizing autonomy and customization.
-
Liquidated all liquid crypto assets to secure a $6M cash runway, enabling 15 months of operations and avoiding unfavorable financing. Focus is now on robotics and AI, with major product launches, global showcases, and plans to cut manufacturing costs by 50% over two years.
-
Revenue grew 166% for the quarter and 220% for six months, driven by product innovation and strong media exposure. Strategic partnerships, pilot deployments, and a patented vision system position the company for growth, while crypto volatility and market adoption remain key risks.
-
Q1 revenue surged due to a pivot into AI and robotics, with strong media validation at CES and rising order interest. Integration of third-party AIs and expansion plans position the company for growth, while a potential Nasdaq listing is under evaluation.
-
AI-powered humanoid robots with patented skin and vision tech drew major attention at CES, sparking strong interest from diverse industries. Plans include scaling production, expanding sales, and pursuing a Nasdaq listing, while maintaining a focus on ethical design and AI innovation.
Fiscal Year 2024
-
Media exposure at CES 2024 drove a surge in corporate interest and orders, with Q1 revenue nearly matching last year's total. The company holds strong cash reserves, is investing in AI robotics, and expects 2024 to outperform 2023, while managing risks from accounting write-downs and crypto volatility.
-
The company specializes in highly realistic, AI-powered humanoid robots for social and companionship roles, with applications in entertainment, healthcare, and marketing. It is expanding from consumer to corporate markets, aiming to scale full-sized robot sales in 2025.
-
The company develops highly realistic, AI-enabled humanoid robots focused on companionship and social interaction, targeting entertainment, healthcare, and education markets. Well-capitalized and early-stage, it expects to scale sales and visibility through CES and media, with profitability targeted in about two years.
-
Acquisition and rebrand to Realbotix completed, with assets and net income rising sharply. Revenue from the robotics segment is expected to increase significantly next quarter, and management is optimistic about growth as new products and partnerships develop.